Sotera Health EBITDA 2019-2025 | SHC
Sotera Health ebitda from 2019 to 2025. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
| Sotera Health Annual EBITDA (Millions of US $) |
|
|---|---|
| 2024 | $469 |
| 2023 | $444 |
| 2022 | $409 |
| 2021 | $414 |
| 2020 | $361 |
| 2019 | $339 |
| 2018 | $285 |
| Sotera Health Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2025-03-31 | $99 |
| 2024-12-31 | $129 |
| 2024-09-30 | $125 |
| 2024-06-30 | $119 |
| 2024-03-31 | $96 |
| 2023-12-31 | $147 |
| 2023-09-30 | $117 |
| 2023-06-30 | $105 |
| 2023-03-31 | $75 |
| 2022-12-31 | $108 |
| 2022-09-30 | $101 |
| 2022-06-30 | $110 |
| 2022-03-31 | $91 |
| 2021-12-31 | $106 |
| 2021-09-30 | $105 |
| 2021-06-30 | $117 |
| 2021-03-31 | $86 |
| 2020-12-31 | $92 |
| 2020-09-30 | $86 |
| 2020-06-30 | $100 |
| 2020-03-31 | $84 |
| 2019-12-31 | |
| 2018-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $3.616B | $1.100B |
| Sotera Health Company is a provider of mission-critical end-to-end sterilization solutions and lab testing as well as advisory services for the healthcare industry. The company market through businesses which include Sterigenics(R), Nordion(R) and Nelson Labs(R). Sotera Health Company is Sotera Health Company is based in CLEVELAND. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $140.565B | 26.36 |
| Elevance Health (ELV) | United States | $91.235B | 11.77 |
| CVS Health (CVS) | United States | $79.418B | 9.87 |
| Cencora (COR) | United States | $56.719B | 19.73 |
| DiDi Global (DIDIY) | China | $21.932B | 33.29 |
| Natera (NTRA) | United States | $20.928B | 0.00 |
| BioMerieux (BMXMF) | France | $15.355B | 0.00 |
| Solventum (SOLV) | United States | $13.109B | 13.88 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $11.943B | 0.00 |
| CochLear (CHEOY) | Australia | $11.734B | 0.00 |
| Revvity (RVTY) | United States | $11.115B | 19.13 |
| ICON (ICLR) | Ireland | $10.559B | 9.82 |
| Viatris (VTRS) | United States | $10.281B | 3.53 |
| Doximity (DOCS) | United States | $10.038B | 46.76 |
| Avantor (AVTR) | United States | $9.104B | 13.23 |
| Medpace Holdings (MEDP) | United States | $8.794B | 23.36 |
| HealthEquity (HQY) | United States | $8.442B | 41.53 |
| Sonic Healthcare (SKHHY) | Australia | $8.311B | 0.00 |
| Charles River Laboratories (CRL) | United States | $6.944B | 13.61 |
| Amplifon S.p.A (AMFPF) | Italy | $4.966B | 26.21 |
| BrightSpring Health Services (BTSG) | United States | $4.201B | 38.89 |
| Bausch + Lomb (BLCO) | Canada | $4.160B | 24.52 |
| Alignment Healthcare (ALHC) | United States | $3.213B | 0.00 |
| Surgery Partners (SGRY) | United States | $3.025B | 39.33 |
| Concentras Parent (CON) | United States | $2.892B | 16.71 |
| Organon (OGN) | United States | $2.340B | 2.49 |
| Ardent Health Partners (ARDT) | United States | $2.167B | 9.24 |
| GeneDx Holdings (WGS) | United States | $2.026B | 78.04 |
| Premier (PINC) | United States | $1.903B | 14.44 |
| Progyny (PGNY) | United States | $1.843B | 40.57 |
| PACS (PACS) | United States | $1.623B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.411B | 28.21 |
| Teladoc Health (TDOC) | United States | $1.282B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.277B | 9.72 |
| Establishment Labs Holdings (ESTA) | $1.065B | 0.00 | |
| Ryman Healthcare (RYHTY) | New Zealand | $0.998B | 0.00 |
| CareDx (CDNA) | United States | $0.986B | 15.39 |
| Nutex Health (NUTX) | United States | $0.981B | 14.82 |
| Agilon Health (AGL) | United States | $0.969B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.858B | 8.04 |
| QDM (QDMI) | Hong Kong, SAR China | $0.729B | 0.00 |
| Embecta (EMBC) | United States | $0.679B | 4.57 |
| InnovAge Holding (INNV) | United States | $0.566B | 0.00 |
| Enhabit (EHAB) | United States | $0.539B | 44.38 |
| Auna S.A (AUNA) | Luxembourg | $0.524B | 13.88 |
| Sonida Senior Living (SNDA) | United States | $0.494B | 0.00 |
| LifeMD (LFMD) | United States | $0.481B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.404B | 0.00 |
| SBC Medicals (SBC) | United States | $0.353B | 0.00 |
| Oncology Institute (TOI) | United States | $0.231B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.211B | 0.00 |
| Beauty Health (SKIN) | United States | $0.205B | 0.00 |
| DocGo (DCGO) | United States | $0.148B | 24.17 |
| Sera Prognostics (SERA) | United States | $0.087B | 0.00 |
| So-Young (SY) | China | $0.087B | 0.00 |
| KindlyMD (KDLY) | United States | $0.084B | 0.00 |
| OncoCyte (OCX) | United States | $0.080B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.063B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.057B | 0.00 |
| Biodesix (BDSX) | United States | $0.044B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.039B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.033B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.032B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.013B | 0.00 |
| ModivCare (MODV) | United States | $0.013B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.010B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.009B | 0.00 |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |